Pernix Therapeutics Holdings (PTX) Posts Q3 Loss of 16c/Share

November 12, 2013 8:39 AM EST Send to a Friend
Pernix Therapeutics Holdings (NASDAQ: PTX) reported Q3 EPS of ($0.16) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login